Hims & Hers Health Inc’s recently made public that its Chief Operating Officer Baird Melissa unloaded Company’s shares for reported $1.15 million on Oct 07 ’24. In the deal valued at $19.57 per share,58,750 shares were sold. As a result of this transaction, Baird Melissa now holds 630,166 shares worth roughly $-12.92 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Okupe Oluyemi sold 9,868 shares, generating $196,992 in total proceeds. Upon selling the shares at $19.96, the Chief Financial Officer now owns 195,988 shares.
Before that, Melissa Baird bought 58,750 shares. Hims & Hers Health Inc shares valued at $1,142,100 were divested by the Officer at a price of $19.44 per share.
Needham initiated its Hims & Hers Health Inc [HIMS] rating to a Buy in a research note published on August 22, 2024; the price target was $24. A number of analysts have revised their coverage, including Imperial Capital’s analysts, who decreased its forecast for the stock in early August from “an Outperform” to “an In-line”. Citigroup also remained covering HIMS and has decreased its forecast on May 22, 2024 with a “Neutral” recommendation from previously “Buy” rating. Jefferies revised its rating on April 16, 2024. It rated HIMS as “a Hold” which previously was an “a Buy”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 9.68% to $20.50. Over the last five days, the stock has gained 5.45%. Hims & Hers Health Inc shares have risen nearly 130.34% since the year began. Nevertheless, the stocks have risen 229.58% over the past one year. While a 52-week high of $25.74 was reached on 06/18/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $16.52, while 200 days put it at $15.43.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 19.74, which if violated will result in even more drops to 18.97. On the upside, there is a resistance level at 21.23. A further resistance level may holdings at 21.95. The Relative Strength Index (RSI) on the 14-day chart is 64.85, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.57, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.42%. Stochastics %K at 66.42% indicates the stock is a holding.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-09-30, dropping by -3.27 million shares to a total of 24.76 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 28.04 million shares. There was a decline of -13.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 10, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
